Epidemiological novelties in lung cancer;Épidémiologie du cancer bronchique primitif: aspects classiques et nouveautés

Revue des Maladies Respiratoires

Volumn 28, Issue 8, 2011, Pages 1048-1058

  Quoix, E ^a   Lemarie E ^b  

^a HÔPITAL CIVIL   (France)

^b CHU BRETONNEAU   (France)

Author keywords

Cannabis; Environmental tobacco smoke; Epidemiology; Hormone replacement therapy; Lung cancer; Occupational lung cancer; Pollution; Tobacco smoking

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER RISK; CANNABIS SMOKING; DISEASE PREDISPOSITION; FRANCE; JAPAN; LUNG CANCER; OCCUPATIONAL HAZARD; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA;

EID: 84155163944     PISSN: 07618425     EISSN: 17762588     Source Type: Journal    
DOI: 10.1016/j.rmr.2010.12.015     Document Type: Review

References (101)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 2010:17.
2. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81.
3. Belot A, Grosclaude P, Bossard N, et al. Incidence et mortalité par cancer en France sur la période 1980-2005. Rev Epidemiol Sante Publique 2008;56:159-75.
4. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest 2005;128:370-81. (Pubitemid 40994497)
5. Davidoff AJ, Tang M, Seal B, Edelman MJ. Chemotherapy and survival benefit in elderly patients with advanced non-smallcell lung cancer. J Clin Oncol 2008;29(28):1257-63.
6. Blanchon F, Grivaux M, Collon T, et al. Epidémiologie du cancer bronchique primitif et prise en charge dans les hôpitaux généraux français. Rev Mal Respir 2002;19:727-34. (Pubitemid 36019711)
7. Foegle J, Hedelin G, Lebitasy MP, et al. Non-small-cell lung cancer in a French department (1982-1997): management and outcome. Br J Cancer 2005;92:459-66. (Pubitemid 40403033)
8. Gregor A, Thomson CS, Brewster DH, et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population-based study. Thorax 2001;56:212-7.
9. Mahmud SM, Reilly M, Comber H. Patterns of initial management of lung cancer in the Republic of Ireland: a population-based study. Lung Cancer 2003;41:57-64. (Pubitemid 36765484)
10. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol 2005;23:3175-85. (Pubitemid 46217457)
11. Charloux A, Quoix E, Wolkove N, et al. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol 1997;26:14-23. (Pubitemid 27129564)
12. Kubina M, Hedelin G, Charloux A, et al. Les habitudes tabagiques des patients ayant un cancer épidermoïde ou un adénocarcinome bronchique diffèrent-elles ? Rev Mal Respir 1999;16:539-49. (Pubitemid 29484965)
13. Thun MJ, Lally CA, Flannery JT, et al. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997;89:1580-6. (Pubitemid 27479717)
14. Doll R, Hill A. A study of the aetiology of carcinoma of the lung. Br Med J 1950;2:740-8.
15. Hill C. Le point sur l'épidémie de cancer du poumon dû au tabagisme. BEH 2010;19-20:210-3.
16. Zhang H, Cai B. The impact of tobacco on lung health China. Respirology 2003;8:17-21. (Pubitemid 36504276)
17. The health effects of active smoking: a report of the surgeon general 2004. In: US government printing office, US Department of health and human services: Washington, DC; 2004.
18. Wirth N, Bohadona A, Spinoza A, et al. Les pathologies respiratoires liées au tabagisme passif. Rev Mal Respir 2009;26:667-78.
19. Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. Br Med J 1981;282:183-5. (Pubitemid 11188565)
20. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer environmental tobacco smoke. Br Med J 1997;315:980-8. (Pubitemid 27443125)
21. Hackshaw A, Law M, Wald N. Lung cancer and passive smoking. Increased risk is not disputed. Br Med J 2000;321:1221-2 [discussion 1222-3].
22. Boffetta P, Agudo A, Ahrens W, et al. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998;90:1440-50. (Pubitemid 28482008)
23. Zhong L, Goldberg MS, Parent ME, et al. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer 2000;27:3-18.
24. Vineis P, Airoldi L, Veglia P, et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never-smokers in the EPIC prospective study. BMJ 2005;330:277 [Epub 2005 Jan 28].
25. IARC working group of the evaluation of carcinogenic risks to humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.
26. Vineis P, Thomas T, Hayes RB, et al. Proportion of lung cancers in males, due to occupation, in different areas of the USA. Int J Cancer 1988;42:851-6. (Pubitemid 19012913)
27. Rushton L, Bagga S, Bevan R, et al. Occupation and cancer in Britain. Br J Cancer 1428;102:1428-37.
28. Boffetta P, Autier P, Boniol M, et al. An estimate of cancers attributable to occupational exposures in France. J Occup Environ Med 2010;52:399-406.
29. Scarselli A, Massari S, Binazzi A, et al. Italian national register of occupational cancers: data system and findings. J Occup Environ Med 2010;52:346-53.
30. Lemen RA, Dement JM, Wagoner JK. Epidemiology of asbestos-related diseases. Environ Health Perspect 1980;34:1-11. (Pubitemid 10016958)
31. Vida S, Pintos J, Parent ME, et al. Occupational exposure to silica and lung cancer: pooled analysis of two case-control studies in Montreal, Canada. Cancer Epidemiol Biomarkers Prev 1602;19:1602-11.
32. Utell MJ, Maxim LD. Refractory ceramic fiber (RCF) toxicity and epidemiology: a review. Inhal Toxicol 2010;22:500-21.
33. Olsson A, Kromhout H, Agostini M, et al. A case-control study of lung cancer nested in a cohort of european asphalt workers. Environ Health Perspect 2010;118:1418-24.
34. Gamble J. Lung cancer and diesel exhaust: a critical review of the occupational epidemiology literature. Crit Rev Toxicol 2010;40:189-244.
35. Beveridge R, Pintos J, Parent ME, et al. Lung cancer risk associated with occupational exposure to nickel, chromium VI, and cadmium in two population-based case-control studies in Montreal. Am J Ind Med 2010;53:476-85.
36. Bachand A, Mundt KA, Mundt DJ, et al. Meta-analyses of occupational exposure as a painter and lung and bladder cancer morbidity and mortality 1950-2008. Crit Rev Toxicol 2010;40:101-25.
37. Guha N, Merletti F, Steenland NK, et al. Lung cancer risk in painters: a meta-analysis. Environ Health Perspect 2009;118:303-12.
38. Hollins DM, McKinley MA, Williams C, et al. Beryllium and lung cancer: a weight of evidence evaluation of the toxicological and epidemiological literature. Crit Rev Toxicol 2009;39:1-32.
39. Olsson AC, Fevotte J, Fletcher T, et al. Occupational exposure to polycyclic aromatic hydrocarbons and lung cancer risk: a multicenter study in Europe. Occup Environ Med 2009;67:98-103.
40. Melloni B, Vergnenegre A, Lagrange P, et al. Exposition domestique au radon. Rev Mal Respir 2000;17:1061-71.
41. Darby S, Hill D, Deo H, et al. Residential radon and lung cancer-detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand J Work Environ Health 2006;32:1-83.
42. Amabile JC, Leuraud K, Vacquier B, et al. Multifactorial study of the risk of lung cancer among French uranium miners: radon, smoking and silicosis. Health Phys 2009;97:613-21.
43. Vineis P, Forastiere F, Hoek G, et al. Outdoor air pollution lung cancer: recent epidemiologic evidence. Int J Cancer 2004;111:647-52. (Pubitemid 39062885)
44. Dockery DW, Pope 3rd CA, Xu X, et al. An association between air pollution and mortality in six US cities. N Engl J Med 1993;329:1753-9. (Pubitemid 23355547)
45. Miller AB, Altenburg HP, Bueno-de-Mesquita B, et al. Fruits and vegetables and lung cancer: findings from the European prospective investigation into cancer and nutrition. Int J Cancer 2004;108:269-76. (Pubitemid 37541782)
46. Aldington S, Harwood M, Cox B, et al. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008;31: 280-6.
47. Berthiller J, Straif K, Boniol M, et al. Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol 2008;3:1398-403.
48. Hashibe M, Straif K, Tashkin DP, Morgenstern H, Greenland S, Zhang ZF. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005;35:265-75. (Pubitemid 41079926)
49. Han B, Gfroerer JC, Colliver JD. Associations between duration of illicit drug use and health conditions: results from the 2005-2007 national surveys on drug use and health. Ann Epidemiol 2010;20:289-97.
50. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol 2001;2:506-13. (Pubitemid 33586306)
51. Minami H, Yoshimura M, Miyamoto Y, et al. Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer. Chest 2000;118:1603-9. (Pubitemid 32001783)
52. Subramanian J, Govindan R. Lung cancer in never-smokers: a review. J Clin Oncol 2007;25:561-70.
53. Wu-Williams AH, Dai XD, Blot W, et al. Lung cancer among women in north-east China. Br J Cancer 1990;62:982-7.
54. Thun MJ, Henley SJ, Burns D, et al. Lung cancer death rates in lifelong non-smokers. J Natl Cancer Inst 2006;98: 691-9. (Pubitemid 43832505)
55. Nordquist LT, Simon GR, Cantor A, et al. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004;126:347-51. (Pubitemid 39093415)
56. Quoix E, Monnet I, Scheid P, et al. Management and outcome of French elderly patients with lung cancer: an IFCT survey. Rev Mal Respir 2010;27:421-30 [Epub 2010 Mar 25].
57. Riely GJ, Marks J, Pao W. K-RAS mutations in non-small cell lung cancer. Proc Am Thorac Soc 2009;6:201-5.
58. Wakelee HA, Chang ET, Gomez SL, et al. Lung cancer incidence in never-smokers. J Clin Oncol 2007;25:472-8.
59. Blair A, Freeman LB. Lung cancer among non-smokers. Epidemiology 2006;17:601-3.
60. Gazdar AF, Thun MJ. Lung cancer, smoke exposure, and sex. J Clin Oncol 2007;25:469-71. (Pubitemid 350002950)
61. Foegle J, Hedelin G, Lebitasy MP, et al. Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997. J Thorac Oncol 2007;2:466-74. (Pubitemid 47171800)
62. Piquet J, Blanchon F, Grivaux M, et al. Primary lung cancer in elderly subjects in France. Rev Mal Respir 2004;21: 8S70-78S.
63. Lebitasy M, Monnet I, Depierre A, et al. Management of elderly lung cancer patients in France: a national prospective survey by the French intergroup of thoracic oncology (IFCT). J Clin Oncol 2004;22:8163.
64. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
65. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20,561 cases. Ann Oncol 2002;13:1087-93.
66. Mennecier B, Lebitasy MP, Moreau L, et al. Women and small cell lung cancer: social characteristics, medical history, management and survival: a retrospective study of all the male and female cases diagnosed in Bas-Rhin (Eastern France) between 1981 and 1994. Lung Cancer 2003;42: 141-52. (Pubitemid 37270623)
67. Visbal AL, Williams BA, Nichols 3rd FC, et al. Gender differences in non-small-cell lung cancer survival: an analysis of 4618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004;78:209-15 [discussion 215]. (Pubitemid 38842439)
68. Risch H, Howe G, Jain M, et al. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type [see comments]. Am J Epidemiol 1993;138:281-93. (Pubitemid 23263599)
69. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996;88:183-92. (Pubitemid 26065830)
70. Lubin JH, Blot WJ. Assessment of lung cancer risk factors by histologic category. JNCI 1984;73:383-9. (Pubitemid 14055218)
71. Bain C, Feskanich D, Speizer FE, et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004;96:826-34. (Pubitemid 38807603)
72. Freedman ND, Leitzmann MF, Hollenbeck AR, et al. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 2008;9:649-56 [Epub 2008 Jun 13].
73. Kreuzer M, Boffetta P, Whitley E, et al. Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy. Br J Cancer 2000;82:227-33. (Pubitemid 30008986)
74. Prescott E, Osler M, Hein H, et al. Gender and smoking-related risk of lung cancer. The Copenhagen center for prospective population studies. Epidemiology 1998;9:79-83.
75. Quoix E, Mennecier B. Lung cancer in women. Rev Mal Respir 2005;22:8S55-62S.
76. Thun MJ, Henley SJ, Calle EE. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 2002;21:7307-25. (Pubitemid 35314509)
77. Ryberg D, Hewer A, Phillips DH, et al. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994;54:5801-3. (Pubitemid 24375208)
78. Mollerup S, Ryberg D, Hewer A, et al. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 1999;59:3317-20. (Pubitemid 29334483)
79. Wei Q, Cheng L, Amos C, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92: 1764-72.
80. Nelson HH, Christiani DC, Mark EJ, et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999;91:2032-8.
81. Wang Y, Lee HS, Chen S, et al. Analysis of K-Ras gene mutations in lung carcinomas: correlation with gender, histological subtypes and clinical outcomes. J Cancer Res Clin Oncol 1998;124:517-22. (Pubitemid 28474163)
82. Kure EH, Ryberg D, Hewer A, et al. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis 1996;17:2201-5. (Pubitemid 26372059)
83. Gealy R, Zhang L, Siegfried JM, et al. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and non-smoking women. Cancer Epidemiol Biomarkers Prev 1999;8:297-302. (Pubitemid 29193900)
84. Tseng JE, Rodriguez M, Ro J, et al. Gender differences in p53 mutational status in small cell lung cancer. Cancer Res 1999;59:5666-70.
85. Bennett WP, Alavanja MC, Blomeke B, et al. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 1999;91:2009-14.
86. Ruano-Ravina A, Figueiras A, Loidi L, et al. GSTM1 and GSTT1 polymorphisms, tobacco and risk of lung cancer: a case-control study from Galicia, Spain. Anticancer Res 2003;23:4333-7. (Pubitemid 37474943)
87. Tang DL, Rundle A, Warburton D, et al. Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis 1998;19:1949-53. (Pubitemid 28521936)
88. Tricker AR. Re: environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 2000;92:760-1. (Pubitemid 30365541)
89. Malats N, Camus-Radon AM, Nyberg F, et al. Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 2000;9:827-33. (Pubitemid 30660056)
90. Dressler C, Fratelli C, Babb J, et al. Gender differences in genetic susceptibility for lung cancer. Lung Cancer 2000;30:153-60. (Pubitemid 32007871)
91. Nyberg F, Hou SM, Hemminki K, et al. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in non-smoking and smoking lung cancer patients and population controls. Cancer Epidemiol Biomarkers Prev 1998;7:875-83. (Pubitemid 28471575)
92. Nyberg F, Agrenius V, Svartengren K, et al. Environmental tobacco smoke and lung cancer in nonsmokers: does time since exposure play a role? Epidemiology 1998;9:301-8. (Pubitemid 28194240)
93. Vogel U, Laros I, Jacobsen NR, et al. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 2004;546:65-74. (Pubitemid 38130220)
94. Shriver SP, Bourdeau HA, Gubish CT, et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 2000;92:24-33. (Pubitemid 30082225)
95. Cavalieri E, Frenkel K, Liehr JG, et al. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 2000;27:75-93.
96. Fishman J. Biological action of catechol oestrogens. J Endocrinol 1981;89:59P-65P. (Pubitemid 11039102)
97. Taioli E, Wynder EL. Re: endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994;86:869-70.
98. Slatore CG, Chien JW, Au DH, et al. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol 1540;28:1540-6.
99. Chlebowski RT, Schwartz AG, Wakelee H, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet 2009;374:1243-51 [Epub 2009 Sep 18].
100. Marquez-Garban DC, Chen HW, Goodglick L, et al. Targeting aromatase and estrogen signaling in human nonsmall cell lung cancer. Ann N Y Acad Sci 2009;1155: 194-205.
101. Traynor AM, Schiller JH, Stabile LP, et al. Pilot study of gefitinib and fulvestrant in the treatment of postmenopausal women with advanced non-small cell lung cancer. Lung Cancer 2009;64:51-9 [Epub 2008 Aug 12].